Chipscreen
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (37)
A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
Started: 12/6/2024
Tucidinostat in Combination With CHOP in Newly Diagnosed Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype
Started: 8/12/2025
Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
Started: 12/20/2021
Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCL
Started: 5/21/2020
Chiauranib Plus PD-1 Inhibitor, Albumin-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Started: 3/31/2026
Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer
Started: 3/5/2021
Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer
Started: 7/1/2015
Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients
Started: 9/1/2014
Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients
Started: 6/1/2014
Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
Started: 8/13/2024
Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)
Started: 8/25/2022
A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
Started: 11/5/2021
Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.
Started: 11/23/2021
A Study of Tucidinostat Combined With Tislelizumab as First-line Treatment in Advanced NSCLC
Started: 10/26/2022
Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer
Started: 7/1/2019
Chidamide in Combination With Carboplatin and Paclitaxel in Advanced Non-small Cell Lung Cancer
Started: 4/1/2013
A Study of CS23546 in Subjects With Advanced Tumors
Started: 3/27/2024
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
Started: 9/8/2025
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid Tumors
Started: 5/21/2025
Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Started: 8/26/2022
A Study of NWY001 in Subjects With Advanced Solid Tumors
Started: 1/5/2024
Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets
Started: 10/8/2026
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 Capsules
Started: 3/28/2024
Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function
Started: 11/20/2022
Pharmacokinetics of Chiglitazar in Subjects With Hepatic Impairment and Normal Hepatic Function
Started: 12/3/2022
Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer
Started: 11/9/2017
Drug-Drug Interaction Study of Chiglitazar in Healthy Subjects.
Started: 2/17/2023
Trial of Chiauranib Capsule on Pharmacokinetics to Assess the Effect of High Fat Diet in Healthy Volunteers
Started: 6/2/2022
Chiauranib in Combination With Chidamide in Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma
Started: 7/11/2019
Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma
Started: 4/28/2018
Phase Ib Study of Chiauranib in Patients With Ovarian Cancer
Started: 12/15/2017
Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's Lymphoma
Started: 5/9/2017
Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients
Started: 8/11/2016
Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
Started: 2/1/2014